Journal of Korean Medicine for Obesity Research : eISSN 2288-1522 / pISSN 1976-9334

Table. 3.

Table. 3.

Characteristics of Interventional Study

No. Author (yr) Characteristics of participants Study size Intervention (n) Control Duration of treatment Outcomes
1 Lee JE 18) (2010) Obese patientBMI≥25 kg/m2 38 Bofu-tsusho-san (18)powder. 1po for each time3 times/day Placebo (18)1po for each time3 times/day 4-5 weeks BW, BMI, WC, WHR, BFM, FFM, PBF, BMR, TFA, VFA, SFA, VSR, TC, TG, HDL, LDL, glucose, CRP, leptin, adioponectin, KOQOL, SRI, KEAT-26, AST, ALT, γ-GT, BUN, Cr
2 Cho YJ 19) (2010) Overweight child (Age 6-11)BMI≥23 kg/m2 46 I-razin (25)1 pack (15 mL) for each time3 times/day Placebo (21)1po (15 mL) for each time3 times/day 8 weeks BW, BMI, WC, visceral fat, blood glucose, TC, TG, AST, ALT
3 Kwon DH 20) (2011) Obese femaleBMI≥25 kg/m2 50 Red Ginseng (26)500 mg 12T for each time3 times/day Placebo (24)500 mg 12T for each time3 times/day 8 weeks BW, BMI, WC, WHR, RMR, BF%, BFM, FI, BBT, KOQOL, FBST, TG, HDL, TC, sBP, dBP, PR, RR, AST, BUN, Cr, ALT
4 Park JH 23) (2012) Obese patientBMI≥25 kg/m2 114 Boiogito (55)244 mg/capsule4 capsules for each time3 times/day Placebo (56)250 mg/capsule4 capsules for each time3 times/day 8 weeks BP, PR, BW, BMI, WC, RMR, ALT, AST, BUN, Cr, glucose, TC, HDL, TG, KOQOL
5 Lee CH 24) (2015) NAFLD 22 Electroacupuncture (11)1 session/wk (25 min for each time) Control (11) 8 weeks AST, ALT, TG, TC, HDL, LDL, BST, γ-GTP, BW, BMI, FM, BFR, WHR, adverse events
6 Choi JB 29) (2017) Obese patientBMI=25.0~29.9 kg/m2 36 Punica granatum L.+Actinidia chinensis Planch. mixed extract (15)1 pack (200 mL/day) for each time2 times/day Placebo (15)1 pack (200 mL/day)2 times/day 8 weeks BW, BMI, BFM, BFR, WC, HC, WHR, TC, TG, LDL, HDL, ALT, AST, BUN, Cr
7 Jin YH 17) (2010) Obese patientBMI≥20 kg/m2 216 Gamitaeeumjowi-tang (60)1 pack (120 cc) for each time3 times/day - 15 days t-BIL, ALP, AST, ALT
8 Ji JG 21) (2011) Overweight femaleBMI≥23 kg/m2 10 Moving cupping therapy (10)12 Meridional dermomeres, 1 session/wk (30 min for each time) - 10 weeks BW, BMI, PBF, WHR, WC, AC, TC, LDL, HDL, TG
9 Song EM 22) (2012) Obese femaleBMI≥25 kg/m2 25 Far-infrared therapy (25)2 sessions/wk (30 min for each time) - 6 weeks BW, WC
10 Lee YH 25) (2015) Obese patient- 254 Herbal medicine (254)1 pack (120 mL) for each time3 times/day - 1 month BW, BMI, FM, skeletal mass, BFP
11 Shin SU 26) (2016) Overweight patientBMI≥23 kg/m2 33 Modified fasting therapy (33)15 days - 15 days BMI, BW, WC, BFM, MM, FFM, PBF, WHR, VFL, BMR, BP, CBC, WBC differential count, T-protein, albumin, globulin, AST, ALT, γ-GTP, ALP, T-bilirubiln, D-bilirubin, BUN, B/C ratio, FBS, TC, HDL, LDL, TG, Na+, K+, Ca+, hs-CRP, CRP, ESR, urinalysis, revised Chalder's fatigue scale, scores for ratingscale for subjective symptoms
12 Lee EJ 27) (2016) Obese patient- 54 Modified fasting therapy (33) - 5 weeks BW, BMI, PBF, MM, WHR, VFL, BMR, adverse events
13 Shin WY 28) (2017) Obese femaleBMI≥25 kg/m2 344 Herbal medicine (344)50.8~72 g/day - ≥15 days BW, BF, muscular volume, BMI, BFR
14 Yoon NR 30) (2018) Obese patient- 124 Gamitaeeumjowi-tang (124)1 pack (120 cc) for each time3 times/day - 10 weeks WHO-UMC causality categories, LDS scale, adverse events according to SOC

BMI: body mass index, BW: body weight, WC: waist circumference, WHR: waist-hip ratio, BFM: body fat mass, FFM: fat free mass, PBF: percent body fat, BMR: body metabolic rate, TFA: total fat area, VFA: visceral fat area, SFA: subcutaneous fat area, VSR: VFA/SFA ratio, TC: total cholesterol, TG: triglyceride, HDL: high-density lipoprotein, LDL: low-density lipoprotein, CRP: C-reactive protein, KOQOL: Korean version of obesity-related quality of life scale, SRI: stress response inventory, KEAT-26: Korean eating attitude test-26, AST: aspartate aminotransferase, ALT: alanine aminotransferase, γ-GT: γ-glutamic acid peptide transferase, BUN: blood urea nitrogen, Cr: creatine, RMR: resting metabolic rate, BF%: body fat %, FI: food intake, BBT: basal body temperature, FBST: fasting bllod sugar test, sBP: systolic blood pressure, dBP: diastolic blood pressure, PR: pulse rate, RR: RR interval, BP: blood pressure, NAFLD: non-alcoholic fatty liver disease, BST: blood sugar test, γ-GTP: γ-glutamyltranspeptidase, HC: hip circumference, t-BIL: total bilirubin, ALP: alkaline phosphatase, AC: arm circumference, FM: fat mass, MM: muscle mass, VFL: visceral fat level, CBC: complete blood count, WBC: white blood cell, T-protein: total protein, T-bilirubiln: total bilirubin, D-bilirubin: direct bilirubin, B/C ratio: bun/creatinine ratio, FBS: fasting blood sugar, hs-CRP: high sensitive C-reactive protein, ESR: erythrocyte sedimentation rate, BFR: body fat ratio, WHO-UMC Causality categories: World Health Organization-Uppsala Monitoring Centre Causality categories, SOC: system organ classes.
J Korean Med Obes Res 2020;20:149-77 https://doi.org/10.15429/jkomor.2020.20.2.149
© 2020 J Korean Med Obes Res